These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 27865823)

  • 1. Gut hormones and gut microbiota: implications for kidney function and hypertension.
    Afsar B; Vaziri ND; Aslan G; Tarim K; Kanbay M
    J Am Soc Hypertens; 2016 Dec; 10(12):954-961. PubMed ID: 27865823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension as a Metabolic Disorder and the Novel Role of the Gut.
    Tanaka M; Itoh H
    Curr Hypertens Rep; 2019 Jun; 21(8):63. PubMed ID: 31236708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal inhibition of the Na+/H+ exchanger 3 prevents cardiorenal damage in rats and inhibits Na+ uptake in humans.
    Spencer AG; Labonte ED; Rosenbaum DP; Plato CF; Carreras CW; Leadbetter MR; Kozuka K; Kohler J; Koo-McCoy S; He L; Bell N; Tabora J; Joly KM; Navre M; Jacobs JW; Charmot D
    Sci Transl Med; 2014 Mar; 6(227):227ra36. PubMed ID: 24622516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic inhibition of intestinal sodium uptake: a gut centric approach to sodium management.
    Spencer AG; Greasley PJ
    Curr Opin Nephrol Hypertens; 2015 Sep; 24(5):410-6. PubMed ID: 26197202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium, hypertension, and the gut: does the gut microbiota go salty?
    Smiljanec K; Lennon SL
    Am J Physiol Heart Circ Physiol; 2019 Dec; 317(6):H1173-H1182. PubMed ID: 31585045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of intestinal barrier and microbiota in chronic kidney disease.
    Sabatino A; Regolisti G; Brusasco I; Cabassi A; Morabito S; Fiaccadori E
    Nephrol Dial Transplant; 2015 Jun; 30(6):924-33. PubMed ID: 25190600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota, hypertension and chronic kidney disease: Recent advances.
    Sircana A; De Michieli F; Parente R; Framarin L; Leone N; Berrutti M; Paschetta E; Bongiovanni D; Musso G
    Pharmacol Res; 2019 Jun; 144():390-408. PubMed ID: 29378252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease.
    Yang T; Richards EM; Pepine CJ; Raizada MK
    Nat Rev Nephrol; 2018 Jul; 14(7):442-456. PubMed ID: 29760448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiome and kidney disease: a bidirectional relationship.
    Al Khodor S; Shatat IF
    Pediatr Nephrol; 2017 Jun; 32(6):921-931. PubMed ID: 27129691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Myth of Water and Salt: From Aquaretics to Tenapanor.
    Visconti L; Cernaro V; Calimeri S; Lacquaniti A; De Gregorio F; Ricciardi CA; Lacava V; Santoro D; Buemi M
    J Ren Nutr; 2018 Mar; 28(2):73-82. PubMed ID: 29146141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of NHE3-mediated Sodium Absorption in the Gut Reduced Cardiac End-organ Damage Without Deteriorating Renal Function in Obese Spontaneously Hypertensive Rats.
    Linz B; Hohl M; Reil JC; Böhm M; Linz D
    J Cardiovasc Pharmacol; 2016 Mar; 67(3):225-31. PubMed ID: 26727380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.
    Mafra D; Lobo JC; Barros AF; Koppe L; Vaziri ND; Fouque D
    Future Microbiol; 2014; 9(3):399-410. PubMed ID: 24762311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of resistant hypertension in chronic kidney disease.
    Campese VM
    Semin Nephrol; 2014; 34(5):571-6. PubMed ID: 25416666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota in hypertension.
    Jose PA; Raj D
    Curr Opin Nephrol Hypertens; 2015 Sep; 24(5):403-9. PubMed ID: 26125644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.
    Pan W; Kang Y
    Int Urol Nephrol; 2018 Feb; 50(2):289-299. PubMed ID: 28849345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond gut feelings: how the gut microbiota regulates blood pressure.
    Marques FZ; Mackay CR; Kaye DM
    Nat Rev Cardiol; 2018 Jan; 15(1):20-32. PubMed ID: 28836619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease.
    Onal EM; Afsar B; Covic A; Vaziri ND; Kanbay M
    Hypertens Res; 2019 Feb; 42(2):123-140. PubMed ID: 30504819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of gut microbiota on kidney function and pathogenesis.
    Mahmoodpoor F; Rahbar Saadat Y; Barzegari A; Ardalan M; Zununi Vahed S
    Biomed Pharmacother; 2017 Sep; 93():412-419. PubMed ID: 28654798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota in kidney disease and hypertension.
    Antza C; Stabouli S; Kotsis V
    Pharmacol Res; 2018 Apr; 130():198-203. PubMed ID: 29496593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-talk between gut microbiome, salt and hypertension.
    Naqvi S; Asar TO; Kumar V; Al-Abbasi FA; Alhayyani S; Kamal MA; Anwar F
    Biomed Pharmacother; 2021 Feb; 134():111156. PubMed ID: 33401080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.